Viruses in Cancer Etiology
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Epidemiology and Prevention".
Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 9889
Special Issue Editors
Interests: head and neck cancer; HPV-associated malignancies; p53
Special Issues, Collections and Topics in MDPI journals
2. Department of Pathology and Lab Medicine, The University of North Carolina, Chapel Hill, NC 27599, USA
3. Lineberger Comprehensive Cancer Center, The University of North Carolina, Chapel Hill, NC 27599, USA
Interests: head and neck cancer; HPV; HPV carcinogenesis
Special Issue Information
Dear Colleagues,
In total, around 10 to 20% of human cancers are caused by oncogenic viruses. At least seven viruses–Epstein–Barr virus, human papillomavirus, human T-cell lymphotropic virus, hepatitis B and C viruses, Kaposi's sarcoma herpesvirus, and Merkel cell polyomavirus–have well-established roles in cancer progression and are relatively well-studied. These seven viruses belong to diverse taxonomic groups and infect different types of cells, resulting in the development of specific malignant tumors; however, they share several common features that contribute to their transformation, including their ability to regulate host cell proliferation and apoptosis, as well as immune response, in order to establish a chronic infection, and their propensity to inhibit tumor suppressors p53 and Rb.
Furthermore, a number of other viruses, usually not viewed as oncogenic, have been connected to human malignancies. Thus, almost half of human cancers have somatic retrotranspositions of long interspersed nuclear elements (Line1)—a repetitive element resembling retroviruses—and Line1-driven retrotransposition is a documented source of complex structural genomic aberrations and mutations in esophageal, head and neck, lung, and other tumors. Additionally, although not satisfactory and controversial, data exist indicating some involvement of simian vacuolating virus 40 (SV40) and human cytomegalovirus in cancer etiology.
The unique infectious nature of oncogenic viruses differentiatess them from other common causes of cancer and creates opportunities for exclusive anti-cancer treatments and cancer prevention, including some types of immunotherapies and prophylactic vaccination.
In this Special Issue, we welcome basic, translational, and clinical research papers, as well as comprehensive reviews, in the field of virus-associated cancer.
Dr. Natalia Issaeva
Prof. Dr. Wendell G. Yarbrough
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oncogenic viruses
- virus-related cancers
- cancer progression
- immune response
- cancer etiology
- anti-cancer treatment
- immunotherapies
- prophylactic vaccination